2010 News
-
Press Release IR News
Santen Launches DIQUAS Ophthalmic Solution 3% for Dry Eye Treatment in Japan
-
Press Release IR News
Santen Announces Financial Result for the Second Quarter ended September 30, 2010
-
Press Release IR News
Reorganization of manufacturing function and transfer of Osaka plant
-
Press Release IR News
Santen Announces Financial Result for the First Quarter ended June 30, 2010
-
Press Release IR News
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)
-
Press Release IR News
Notice on the Allotment of Stock Options (Stock Acquisition Rights)
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Results for the Year ended March 31, 2009
-
Press Release IR News
-
Press Release IR News
Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Directors
-
Press Release IR News
Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Corporate Officers
-
Press Release IR News
-
Press Release IR News
Santen Launches Glaucoma and Ocular Hypertension Treatment TAFLOTAN® in Korea
-
Press Release IR News
-
Press Release IR News
Santen Announces Approval of DIQUAS for Dry Eye Treatment in Japan
-
Press Release IR News
MHLW Grants Approval for COSOPT Combination Ophthalmic Solution
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Result for the Third Quarter ended December 31, 2009